Laird Thermal Systems Releases Its Next Generation of Eco-Friendly Recirculating Chillers for Precise Temperature Control of Analytical, Medical and Industrial Equipment

Laird Thermal Systems announced they have released its next generation of eco-friendly recirculating chillers for precise temperature control of analytical, medical and industrial equipment.

The Nextreme Recirculating Chiller platform features high-quality components, environmentally friendly refrigerants, low-noise components and a user-friendly operator interface at a standard price. The new chiller utilizes high-performance variable speed motors for noise reduction, lower room heat input and reduced energy consumption by up to 50% compared to conventional compressor-based systems.

The Nextreme Recirculating Chiller platform is designed with a semi-open coolant system which offers several advantages including decreased bacterial growth and evaporation while still being easy to maintain. The chiller utilizes high quality components that minimize downtime and features sensor instrumentation that provides system status and the ability to integrate predictive maintenance / failure analysis. By using environmentally-friendly R513A refrigerant, it delivers similar performance with less than half the Global Warming Potential (GWP) compared to traditional hydrofluorocarbons (HFC) refrigerants.

“The Nextreme Chiller line is designed for OEMs, laboratories and research universities that need an energy-efficient chiller versatile enough to support the cooling needs of their entire equipment installation,” said Greg Ducharme, Product Director at Laird Thermal Systems. “Laboratory technicians, R&D engineers and equipment operators will appreciate the quiet, maintenance-free operation of the system, knowing it also has a lower environmental impact due to its refrigerant type and reduced energy consumption.”

The Nextreme Recirculating Chiller platform cools well below ambient temperature and offers temperature stability of ±0.1°C of the designated temperature. The Nextreme Chiller Series is available with three standard cooling capacities including 1800 W, 2800 W and 5000 W models.

An RS-232 / RS-485 communications interface offers complete control integration of the chiller into a higher-level assembly control system where users can remotely request data or send setpoints to the chiller using communication commands. The LCD touchscreen display allows users to easily control temperature setpoints, coolant type, flow and alarm setting. The Nextreme Chiller platform offers several optional features to meet unique application requirements such as flow control and measurement, coolant filtration, high purity plumbing and more.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version